According to Merck's latest financial reports the company's current EPS (TTM) is $3.07. In 2022 the company made an earnings per share (EPS) of $9.64 an increase over its 2021 EPS that were of $8.69.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.89 | -70% |
2022 | $9.64 | 10.92% |
2021 | $8.69 | 84.68% |
2020 | $4.71 | -27.2% |
2019 | $6.47 | 63.44% |
2018 | $3.96 | 151.11% |
2017 | $1.58 | -54.58% |
2016 | $3.47 | 30.21% |
2015 | $2.66 | -61.99% |
2014 | $7.01 | 180.51% |
2013 | $2.50 | -31.82% |
2012 | $3.66 | 6.62% |
2011 | $3.44 | 626.78% |
2010 | $0.47 | -95.05% |
2009 | $9.55 | 56.36% |
2008 | $6.11 | -449.04% |
2007 | -$1.75 | -150.98% |
2006 | $3.43 | -3.32% |
2005 | $3.55 | -20.08% |
2004 | $4.44 | -10.81% |
2003 | $4.98 | -6.92% |
2002 | $5.35 | 0% |
2001 | $5.35 | 7.43% |
2000 | $4.98 | 17.93% |
1999 | $4.22 | 13.06% |
1998 | $3.74 | 15.63% |
1997 | $3.23 | 20% |
1996 | $2.69 |